Dr. Benjamin Pariente

University Lille 2

BENEFIT OF INFLIXIMAB RE-INTRODUCTION AFTER SUCCESSIVE FAILURE OF INFLIXIMAB AND ADALIMUMAB IN INFLAMMATORY BOWEL DISEASES
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
NKG2D PATHWAY DRIVES TH17 RESPONSE IN CROHN?S DISEASE
2010-10-26
English, Abstract, 2010
Measuring disease progression in Crohn´s disease: Introduction of the Marc Lemann score
2011-01-01
English, Presentation, Clinical aspects, Crohn’s disease, Colon, Screening, Surveillance, Investigation and Diagnosis, Small intestine, MRI, 2011
Takeda - Shared Decision-making in Ulcerative Colitis: Balancing Benefits and Risks to Optimise Outcomes (Takeda Pharmaceuticals International AG)
2018-10-21
English, Presentation, Industry Sponsored Symposia, Takeda Pharmaceuticals International AG, Industry Sponsored Symposia, 2018